Isolated ocular relapse in pediatric acute lymphoblastic leukemia: a case report

Main Article Content

Joseph Van Aerschot, MD
Stéphanie Goes, MD
Ingele Casteels, MD, PhD
Heidi Segers, MD, PhD
Catherine Cassiman, MD, PhD

Abstract

A 5-year-old girl, previously in complete remission from common B-cell acute lymphoblastic leukemia (B-ALL), presented at the University Hospital of Leuven with a unilateral, painless red left eye. Over several weeks, the clinical picture evolved from common conjunctivitis into a painful red eye with iris heterochromia and increased iris vascularization unresponsive to topical and oral antibiotics. No signs of leukemic relapse were detected on comprehensive systemic work-up, including bone marrow and lumbar puncture. Aqueous sampling at this time could not confirm the clinical suspicion of isolated ocular relapse of ALL. Oral prednisolone was initiated, with good clinical response. After discontinuation of steroids, the affected eye developed a hypopyon-like mass in the anterior chamber. Urgent anterior chamber washout was performed. Cytology now confirmed the presence of a leukemic infiltrate, indicating an isolated ocular relapse of common B-ALL. Not only because this was the fourth relapse, but primarily because this patient had already undergone extensive prior treatments, including an allogeneic stem cell transplant just 6 months earlier, there were no systemic therapeutic options available. Palliative radiotherapy to the left orbit was therefore initiated. Two months later, the girl presented with similar symptoms in the right eye, which was also treated with radiotherapy.

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Van Aerschot J, Goes S, Casteels I, Segers H, Cassiman C. Isolated ocular relapse in pediatric acute lymphoblastic leukemia: a case report. Digit J Ophthalmol. Published online May 28, 2026. doi:10.5693.djo.02.2025.12.002
Section
Case Reports

References

Pui CH, Yang JJ, Hunger SP, et al. Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol 2015;33:2938-48.

Pui CH, Mullighan CG, Evans WE, Relling M V. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood 2012;120:1165-74.

Inaba H, Mullighan CG. Pediatric acute lymphoblastic leukemia. Haematologica 2020;105:2524-39.

Russo V, Scott IU, Querques G, Stella A, Barone A, Delle Noci N. Orbital and ocular manifestations of acute childhood leukemia: clinical and statistical analysis of 180 patients. Eur J Ophthalmol 2008;18:619-23.

Ohkoshi K, Tsiaras WG. Prognostic importance of ophthalmic manifestations in childhood leukaemia. Br J Ophthalmol 1992;76:651-5.

Mirshahi R, Ghassemi F, Koochakzadeh L, et al. Ocular manifestations of newly diagnosed acute leukemia patients. J Curr Ophthalmol 2022;34:100-105.

Laimon DN, Sakr DH, Atef B, Shaaban Y. Highlights of ophthalmological manifestations in newly diagnosed acute leukemia: a correlation with hematological parameters. Ann Hematol 2024;103:3519-33.

Yu AM, Chan SC, Iordanous Y, Padmore RF, O’Connor MD. Anterior segment infiltration of acute lymphoblastic leukemia: case report and systematic review. Can J Ophthalmol 2019;54:20-26.

Chocron IM, Morrison DG, Friedman DL, Desai NA, Donahue SP. Ophthalmic manifestations of relapsing acute childhood leukemia. J AAPOS 2015;19:284-6.

Leonardy NJ, Rupani M, Dent G, Klintworth GK. Analysis of 135 autopsy eyes for ocular involvement in leukemia. Am J Ophthalmol 1990;109:436-44.

Adaniya A, Bazterrechea P, Trucco JI, Schlaen BA, Kusminsky G, Saravia MJ. Bilateral macular detachment: xhoroid as a sanctuary of acute lymphoblastic leukemia. Am J Ophthalmol Case Rep 2020 May 13;19:100746.